LRRC37B
geneOn this page
Summary
LRRC37B (leucine rich repeat containing 37B, HGNC:29070) is a protein-coding gene on chromosome 17q11.2, encoding Leucine-rich repeat-containing protein 37B (Q96QE4). It is a selective cancer dependency (DepMap: 37.3% of cell lines).
Predicted to be located in membrane.
Source: NCBI Gene 114659 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 173 total — 1 pathogenic
- Cancer dependency (DepMap): dependent in 37.3% of screened cell lines
- MANE Select transcript:
NM_001321350
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29070 |
| Approved symbol | LRRC37B |
| Name | leucine rich repeat containing 37B |
| Location | 17q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000185158 |
| Ensembl biotype | protein_coding |
| OMIM | 616558 |
| Entrez | 114659 |
Gene structure
Transcript identifiers
Ensembl transcripts: 23 — 11 protein_coding, 8 retained_intron, 3 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000341671, ENST00000543378, ENST00000578118, ENST00000578674, ENST00000579094, ENST00000579206, ENST00000579766, ENST00000580303, ENST00000580871, ENST00000581086, ENST00000581370, ENST00000581786, ENST00000582117, ENST00000582815, ENST00000583204, ENST00000583342, ENST00000583758, ENST00000584368, ENST00000902794, ENST00000902795, ENST00000902796, ENST00000935425, ENST00000941835
RefSeq mRNA: 2 — MANE Select: NM_001321350
NM_001321350, NM_052888
CCDS: CCDS32609, CCDS82102
Canonical transcript exons
ENST00000543378 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001519331 | 32053266 | 32053487 |
| ENSE00002211306 | 32021393 | 32022825 |
| ENSE00002241663 | 32020697 | 32020803 |
| ENSE00002265414 | 32017972 | 32018054 |
| ENSE00002691909 | 32007383 | 32008132 |
| ENSE00003458238 | 32031378 | 32031458 |
| ENSE00003524379 | 32035565 | 32035639 |
| ENSE00003565252 | 32050003 | 32050107 |
| ENSE00003579070 | 32047761 | 32047901 |
| ENSE00003608220 | 32045700 | 32045818 |
| ENSE00003609203 | 32030656 | 32030727 |
| ENSE00003629511 | 32024711 | 32024782 |
| ENSE00003660995 | 32049102 | 32049394 |
| ENSE00003669785 | 32027769 | 32027840 |
| ENSE00003691372 | 32034910 | 32034981 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 96.23.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.1040 / max 123.6226, expressed in 1717 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 160218 | 8.0438 | 1717 |
| 160219 | 0.0602 | 10 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar cortex | UBERON:0002129 | 96.23 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 96.22 | gold quality |
| cerebellum | UBERON:0002037 | 96.18 | gold quality |
| ventricular zone | UBERON:0003053 | 96.10 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 95.94 | gold quality |
| cortical plate | UBERON:0005343 | 95.81 | gold quality |
| ganglionic eminence | UBERON:0004023 | 93.98 | gold quality |
| corpus callosum | UBERON:0002336 | 93.75 | gold quality |
| left testis | UBERON:0004533 | 92.10 | gold quality |
| right testis | UBERON:0004534 | 92.07 | gold quality |
| primary visual cortex | UBERON:0002436 | 91.73 | gold quality |
| pituitary gland | UBERON:0000007 | 91.40 | gold quality |
| testis | UBERON:0000473 | 91.34 | gold quality |
| Ammon’s horn | UBERON:0001954 | 91.26 | gold quality |
| sural nerve | UBERON:0015488 | 91.06 | gold quality |
| brain | UBERON:0000955 | 90.88 | gold quality |
| amygdala | UBERON:0001876 | 90.84 | gold quality |
| nucleus accumbens | UBERON:0001882 | 90.84 | gold quality |
| right uterine tube | UBERON:0001302 | 90.80 | gold quality |
| left ovary | UBERON:0002119 | 90.76 | gold quality |
| temporal lobe | UBERON:0001871 | 90.75 | gold quality |
| right frontal lobe | UBERON:0002810 | 90.72 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 90.62 | gold quality |
| caudate nucleus | UBERON:0001873 | 90.59 | gold quality |
| adenohypophysis | UBERON:0002196 | 90.54 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 90.43 | gold quality |
| granulocyte | CL:0000094 | 90.33 | gold quality |
| putamen | UBERON:0001874 | 90.33 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 90.31 | gold quality |
| ovary | UBERON:0000992 | 90.24 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7303 | no | 179.62 |
| E-MTAB-7381 | no | 50.11 |
| E-ANND-3 | no | 4.50 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
30 targeting LRRC37B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548O-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548W | 99.94 | 71.24 | 3488 |
| HSA-MIR-548Y | 99.94 | 71.28 | 3514 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-5571-5P | 99.49 | 66.99 | 1764 |
| HSA-MIR-3973 | 99.20 | 69.19 | 1990 |
| HSA-MIR-6512-5P | 98.76 | 69.29 | 1195 |
| HSA-MIR-3928-3P | 97.61 | 66.53 | 1096 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 37.3% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- LRRC37B is a human modifier of voltage-gated sodium channels and axon excitability in cortical neurons. (PMID:38134874)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lrrc37 | ENSMUSG00000034239 |
| mus_musculus | Lrrc37a | ENSMUSG00000078632 |
| rattus_norvegicus | Lrrc37a | ENSRNOG00000042025 |
| rattus_norvegicus | Prp2l1 | ENSRNOG00000042833 |
Paralogs (3): LRRC37A (ENSG00000176681), LRRC37A3 (ENSG00000176809), LRRC37A2 (ENSG00000238083)
Protein
Protein identifiers
Leucine-rich repeat-containing protein 37B — Q96QE4 (reviewed: Q96QE4)
Alternative names: C66 SLIT-like testicular protein
All UniProt accessions (7): Q96QE4, F5H5K1, J3KTP0, J3QKM3, J3QL10, J3QLE7, J3QLI7
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96QE4-1 | 1 | yes |
| Q96QE4-2 | 2 |
RefSeq proteins (2): NP_001308279, NP_443120 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR003591 | Leu-rich_rpt_typical-subtyp | Repeat |
| IPR015753 | LRRC37 | Family |
| IPR029423 | LRRC37AB_C | Domain |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR032754 | LRRC37_N | Domain |
Pfam: PF13855, PF14914, PF15779
UniProt features (32 total): sequence conflict 9, repeat 6, region of interest 4, compositionally biased region 4, topological domain 2, glycosylation site 2, signal peptide 1, chain 1, coiled-coil region 1, splice variant 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96QE4-F1 | 53.35 | 0.18 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 358, 789
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 42 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP, chr17q11, KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3, ZWANG_DOWN_BY_2ND_EGF_PULSE, CDC5L_TARGET_GENES, TFEB_TARGET_GENES, ZBTB1_TARGET_GENES, ZNF184_TARGET_GENES, ZNF2_TARGET_GENES, ZNF274_TARGET_GENES, ZNF33A_TARGET_GENES, ZNF410_TARGET_GENES, ZSCAN30_TARGET_GENES, MIR548D_3P, MIR548H_3P_MIR548Z
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
210 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRRC37B | CRLF3 | Q8IUI8 | 723 |
| LRRC37B | UTP6 | Q9NYH9 | 719 |
| LRRC37B | ADAP2 | Q9NPF8 | 691 |
| LRRC37B | RAB11FIP4 | Q86YS3 | 664 |
| LRRC37B | ATAD5 | Q96QE3 | 650 |
| LRRC37B | TEFM | Q96QE5 | 624 |
| LRRC37B | COPRS | Q9NQ92 | 623 |
| LRRC37B | EVI2A | P22794 | 580 |
| LRRC37B | RNF135 | Q8IUD6 | 571 |
| LRRC37B | EVI2B | P34910 | 507 |
| LRRC37B | SUZ12 | Q15022 | 479 |
| LRRC37B | NF1 | P21359 | 445 |
| LRRC37B | NPIPB6 | E9PJ23 | 406 |
| LRRC37B | TMEM255B | Q8WV15 | 380 |
| LRRC37B | OMG | P23515 | 348 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LRRC37B | CFTR | psi-mi:“MI:0915”(physical association) | 0.370 |
| NEK4 | E2F8 | psi-mi:“MI:0914”(association) | 0.350 |
| LRRC37B | HLA-F | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (7): LRRC37B (Affinity Capture-RNA), LRRC37B (Affinity Capture-MS), HLA-F (Affinity Capture-MS), METAP2 (Affinity Capture-MS), MAN2A2 (Affinity Capture-MS), LRRC37B (PCA), LRRC37B (Affinity Capture-RNA)
ESM2 similar proteins: A0A1B0GUW6, A1EGX6, A6NM11, A6NMS7, A6QLF8, D3YU32, I3L273, J3KML8, O35930, O60309, Q08DY0, Q14242, Q2TBI7, Q32KG4, Q32L62, Q3MIW9, Q3TNW5, Q3V0E1, Q4R729, Q5VWK0, Q5VYM1, Q62170, Q659K0, Q68DN1, Q6AZ54, Q6MG22, Q6UXB8, Q6ZRG5, Q8BUE7, Q8K4E0, Q8N307, Q8N3K9, Q8TCU4, Q8WNU4, Q8WXI7, Q95JY5, Q96F05, Q96JA4, Q96M34, Q96M43
Diamond homologs: A6NM11, A6NMS7, O60309, Q49AS3, Q96QE4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
173 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 134 |
| Likely benign | 19 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 981056 | GRCh37/hg19 17q11.2-12(chr17:29989741-32355632) | Pathogenic |
SpliceAI
1548 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:32024781:CT:C | donor_gain | 1.0000 |
| 17:32024783:G:GG | donor_gain | 1.0000 |
| 17:32027841:G:GG | donor_gain | 1.0000 |
| 17:32027845:G:GG | donor_gain | 1.0000 |
| 17:32030728:G:GG | donor_gain | 1.0000 |
| 17:32031455:ACTT:A | donor_gain | 1.0000 |
| 17:32031456:CTT:C | donor_gain | 1.0000 |
| 17:32031459:G:GG | donor_gain | 1.0000 |
| 17:32034901:A:AG | acceptor_gain | 1.0000 |
| 17:32034904:TTTCA:T | acceptor_loss | 1.0000 |
| 17:32034905:TTCAG:T | acceptor_loss | 1.0000 |
| 17:32034906:TCA:T | acceptor_loss | 1.0000 |
| 17:32034907:CAG:C | acceptor_loss | 1.0000 |
| 17:32034908:A:AC | acceptor_loss | 1.0000 |
| 17:32034908:A:AG | acceptor_gain | 1.0000 |
| 17:32034909:G:GA | acceptor_gain | 1.0000 |
| 17:32034909:G:T | acceptor_loss | 1.0000 |
| 17:32034909:GA:G | acceptor_gain | 1.0000 |
| 17:32034909:GAA:G | acceptor_gain | 1.0000 |
| 17:32034909:GAATT:G | acceptor_gain | 1.0000 |
| 17:32034977:TATCT:T | donor_gain | 1.0000 |
| 17:32034978:ATCT:A | donor_gain | 1.0000 |
| 17:32034979:TCT:T | donor_gain | 1.0000 |
| 17:32034980:CT:C | donor_gain | 1.0000 |
| 17:32034981:TGTAA:T | donor_loss | 1.0000 |
| 17:32034982:G:GA | donor_loss | 1.0000 |
| 17:32034982:G:GG | donor_gain | 1.0000 |
| 17:32034983:TA:T | donor_loss | 1.0000 |
| 17:32034984:AAGTA:A | donor_loss | 1.0000 |
| 17:32035563:A:AG | acceptor_gain | 1.0000 |
AlphaMissense
5635 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:32027784:T:A | N589K | 0.982 |
| 17:32027784:T:G | N589K | 0.982 |
| 17:32024754:T:A | W575R | 0.981 |
| 17:32024754:T:C | W575R | 0.981 |
| 17:32024756:G:C | W575C | 0.980 |
| 17:32024756:G:T | W575C | 0.980 |
| 17:32024782:T:C | L584P | 0.980 |
| 17:32035639:T:C | L708P | 0.980 |
| 17:32031393:T:A | N637K | 0.977 |
| 17:32031393:T:G | N637K | 0.977 |
| 17:32030671:T:A | N613K | 0.973 |
| 17:32030671:T:G | N613K | 0.973 |
| 17:32030670:A:T | N613I | 0.970 |
| 17:32024726:C:A | N565K | 0.966 |
| 17:32024726:C:G | N565K | 0.966 |
| 17:32034925:T:A | N664K | 0.964 |
| 17:32034925:T:G | N664K | 0.964 |
| 17:32022743:T:C | C533R | 0.963 |
| 17:32034981:T:C | L683P | 0.963 |
| 17:32030699:T:C | F623L | 0.962 |
| 17:32030701:T:A | F623L | 0.962 |
| 17:32030701:T:G | F623L | 0.962 |
| 17:32024716:T:C | F562S | 0.961 |
| 17:32022743:T:A | C533S | 0.960 |
| 17:32022744:G:C | C533S | 0.960 |
| 17:32031421:T:C | F647L | 0.960 |
| 17:32031423:T:A | F647L | 0.960 |
| 17:32031423:T:G | F647L | 0.960 |
| 17:32031392:A:T | N637I | 0.953 |
| 17:32027774:T:C | L586P | 0.952 |
dbSNP variants (sampled 300 via entrez): RS1000179219 (17:32036266 G>GCTA), RS1000240553 (17:32029013 T>A,G), RS1000292902 (17:32029163 AG>A), RS1000621029 (17:32042299 C>T), RS1000636006 (17:32035967 A>G,T), RS1000678193 (17:32042030 T>A,C), RS1000716461 (17:32011303 A>G), RS1000783298 (17:32049943 TTCTC>T,TTC,TTCTCTC), RS1000791158 (17:32017588 T>G), RS1000843611 (17:32017938 G>A,T), RS1000901414 (17:32049789 C>T), RS1001025312 (17:32023391 G>A), RS1001064507 (17:32011051 C>T), RS1001161316 (17:32046096 A>G), RS1001271955 (17:32053430 G>A)
Disease associations
OMIM: gene MIM:616558 | disease phenotypes: MIM:615972, MIM:618786
GenCC curated gene-disease
Mondo (2): nanophthalmos 4 (MONDO:0014426), Imagawa-Matsumoto syndrome (MONDO:0032916)
Orphanet (2): Nanophthalmos (Orphanet:35612), Imagawa-Matsumoto syndrome (Orphanet:659463)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000817_41 | Height | 3.000000e-08 |
| GCST006151_3 | Memory dysfunction in frontotemporal lobe dementia | 8.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0001072 | memory impairment |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases abundance, increases expression | 2 |
| Valproic Acid | affects expression, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Gallic Acid | increases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Imagawa-Matsumoto syndrome, nanophthalmos 4